<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药渡 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-16T11:12:33+08:00</updated>
  <subtitle>药渡以自有药物大数据为依托，对上市及临床在研药物、药物研究进展和重要药物市场商业动态作出信息整合分析，传递药物创新一手资讯</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>一病一图 | 库欣综合征新疗法-Osilodrostat获FDA/EMA双批准</title>
    <updated>2020-11-15T16:51:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/c9F4siH0ewHCcO7aL874mg</id>
    <link href="https://mp.weixin.qq.com/s/c9F4siH0ewHCcO7aL874mg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>免费入场券！ | 40+行业领袖齐聚，12月千人生物工艺盛会等你来撩！</title>
    <updated>2020-11-15T16:51:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/kJxRN9zDYpEjZ2UVISAnTA</id>
    <link href="https://mp.weixin.qq.com/s/kJxRN9zDYpEjZ2UVISAnTA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【11月17号】抗肿瘤药临床试验影像终点程序标准技术指导原则与FDA&amp;CDE 指南的比较及Recist 1.1用于实体瘤疗效评估</title>
    <updated>2020-11-15T16:51:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/thZa37ttxjil_lhjaCMYJA</id>
    <link href="https://mp.weixin.qq.com/s/thZa37ttxjil_lhjaCMYJA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药渡书店 | 狂欢钜惠：超值半价，买1送1</title>
    <updated>2020-11-15T16:51:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/v3_BAR3H0DJzBFw71E1eNA</id>
    <link href="https://mp.weixin.qq.com/s/v3_BAR3H0DJzBFw71E1eNA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药渡招聘 | 咨询合伙人</title>
    <updated>2020-11-15T16:51:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/x3TOYhHaGzgwAJy1cK_OlQ</id>
    <link href="https://mp.weixin.qq.com/s/x3TOYhHaGzgwAJy1cK_OlQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>曙光乍现—KRAS G12C明星抑制剂的进击之路</title>
    <updated>2020-11-14T21:08:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/i3FItSjdENSJr1qqHPW5Tw</id>
    <link href="https://mp.weixin.qq.com/s/i3FItSjdENSJr1qqHPW5Tw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【抗体盛会·限量免费】抗体药物开发及产业化峰会·2021</title>
    <updated>2020-11-14T21:08:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/G9d2QVhtzOCp8Uh-bnrL1g</id>
    <link href="https://mp.weixin.qq.com/s/G9d2QVhtzOCp8Uh-bnrL1g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【11月17号】抗肿瘤药临床试验影像终点程序标准技术指导原则与FDA&amp;CDE 指南的比较及Recist 1.1用于实体瘤疗效评估</title>
    <updated>2020-11-14T21:08:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/sTENHEoZL-T1PHXQtrBWnA</id>
    <link href="https://mp.weixin.qq.com/s/sTENHEoZL-T1PHXQtrBWnA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药渡书店 | 狂欢钜惠：超值半价，买1送1</title>
    <updated>2020-11-14T21:08:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/_cYezWHh3iSZbSUhEKaWVQ</id>
    <link href="https://mp.weixin.qq.com/s/_cYezWHh3iSZbSUhEKaWVQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药渡招聘 | 客户经理</title>
    <updated>2020-11-14T21:08:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/zIfNBuQQwoSQYoNzWz6PeQ</id>
    <link href="https://mp.weixin.qq.com/s/zIfNBuQQwoSQYoNzWz6PeQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>聚焦药靶 | MRD在血液肿瘤临床研究进展及伴随诊断解决方案</title>
    <updated>2020-11-13T18:49:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/28M3mRroawOYciqL11UMaQ</id>
    <link href="https://mp.weixin.qq.com/s/28M3mRroawOYciqL11UMaQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药品不良反应97.7%？君实生物PD-1副作用到底几何？</title>
    <updated>2020-11-13T18:49:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/VcVWKSl5cCKdROR05sdb6g</id>
    <link href="https://mp.weixin.qq.com/s/VcVWKSl5cCKdROR05sdb6g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【11月17号】抗肿瘤药临床试验影像终点程序标准技术指导原则与FDA&amp;CDE 指南的比较及Recist 1.1用于实体瘤疗效评估</title>
    <updated>2020-11-13T18:49:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/xTNbiChJd3vLbYTX3QUP5w</id>
    <link href="https://mp.weixin.qq.com/s/xTNbiChJd3vLbYTX3QUP5w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>终版日程大公开 | WPMCS第五届全球精准医疗（中国）峰会门票优惠即将截止！</title>
    <updated>2020-11-13T18:49:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/FyLWZAtVVTqeOus75fWrAw</id>
    <link href="https://mp.weixin.qq.com/s/FyLWZAtVVTqeOus75fWrAw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【邀请函】前途汇医药研发创新和投资并购年会（2020年北京）</title>
    <updated>2020-11-13T18:49:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/xtJ5Or7Q5PujpINKLjBRwA</id>
    <link href="https://mp.weixin.qq.com/s/xtJ5Or7Q5PujpINKLjBRwA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿斯利康热销药品被重点监控，你家的品种还好吗？</title>
    <updated>2020-11-13T18:49:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/g_Jc8o-rGFL5VUUc4A5BKg</id>
    <link href="https://mp.weixin.qq.com/s/g_Jc8o-rGFL5VUUc4A5BKg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药渡书店 | 狂欢钜惠：超值半价，买1送1</title>
    <updated>2020-11-13T18:49:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/Ljxzdf7pW3iTwUdJXe_I2A</id>
    <link href="https://mp.weixin.qq.com/s/Ljxzdf7pW3iTwUdJXe_I2A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药渡招聘 | 药学分析师</title>
    <updated>2020-11-13T18:49:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/9Zl4o8mAFICofE6ocv1RLA</id>
    <link href="https://mp.weixin.qq.com/s/9Zl4o8mAFICofE6ocv1RLA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>本固枝荣，共赢之道--医保支付与本土创新药</title>
    <updated>2020-11-12T18:30:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/WDstjwrzNes40DOA3Tuv6g</id>
    <link href="https://mp.weixin.qq.com/s/WDstjwrzNes40DOA3Tuv6g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球首款抗破伤风毒素全人源单抗获批在澳洲进入I 期临床</title>
    <updated>2020-11-12T18:30:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/dpXurDZWXQWIUg7bT1KGqA</id>
    <link href="https://mp.weixin.qq.com/s/dpXurDZWXQWIUg7bT1KGqA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>